Table 2. Clinical and immunological characteristics of adolescents living with HIV and transition readiness.
| Variable | Total (n = 786) | Readiness to transition | ||
|---|---|---|---|---|
| n (%) | Not ready to transition n = 735 n (%) | Ready to transition n = 51 n (%) | P-value | |
| Type of ART site | ||||
| Paediatric | 8 (1.0) | 8 (1.1) | 0 (0.0) | <0.001 |
| Adult | 90 (11.5) | 71 (9.7) | 19 (37.3) | |
| Other | 688 (87.5) | 656 (89.3) | 32 (62.7) | |
| Type of current treatment | ||||
| First line | 549 (69.8) | 513 (69.8) | 36 (70.6) | 0.905 |
| Second line | 237 (30.2) | 222 (30.2) | 15 (29.4) | |
| Time since first ART clinic visit (in months) | 102 ± 74 | 102 ± 74 | 101 ± 73 | 0.943 |
| Time since first ART initiation (in months) | 94 ± 70 | 94 ± 69 | 91 ± 70 | 0.767 |
| Time from first visit to ART start (in months) | 42± 72 | 40 ± 71 | 61 ± 77 | 0.044 |
| First CD4 | 580 ± 948 | 596 ± 981 | 384 ± 320 | 0.073 |
| First viral load | 27618 ± 133295 | 27807 ± 134947 | 25087 ± 110105 | 0.896 |
| Latest viral load | 13599 ± 86587 | 14246 ± 89633 | 4989 ± 17073 | 0.451 |
| Visual adherence scale | 92 ± 29 | 92 ± 30 | 93 ± 9 | 0.694 |